Daniel Arias

Stock Analyst at Stifel

(5.00)
# 8
Out of 5,182 analysts
162
Total ratings
57.61%
Success rate
145.23%
Average return

Stocks Rated by Daniel Arias

10x Genomics
Mar 2, 2026
Maintains: Buy
Price Target: $20$25
Current: $21.42
Upside: +16.71%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $120$130
Current: $87.87
Upside: +47.95%
Qiagen
Feb 6, 2026
Maintains: Hold
Price Target: $45$50
Current: $37.97
Upside: +31.68%
Bio-Techne
Feb 5, 2026
Maintains: Hold
Price Target: $60$65
Current: $52.20
Upside: +24.52%
Illumina
Jan 20, 2026
Maintains: Buy
Price Target: $135$155
Current: $125.44
Upside: +23.57%
Thermo Fisher Scientific
Jan 9, 2026
Maintains: Buy
Price Target: $583$700
Current: $466.70
Upside: +49.99%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $83.93
Upside: +72.76%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450$1,600
Current: $1,264.36
Upside: +26.55%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48$40
Current: $36.22
Upside: +10.44%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14$12
Current: $7.76
Upside: +54.64%
Maintains: Hold
Price Target: $120$110
Current: $87.15
Upside: +26.22%
Upgrades: Buy
Price Target: $260
Current: $178.57
Upside: +45.60%
Maintains: Buy
Price Target: $11$9
Current: $0.86
Upside: +944.57%
Maintains: Buy
Price Target: $17$6
Current: $6.76
Upside: -11.24%
Downgrades: Hold
Price Target: $45$65
Current: $51.44
Upside: +26.36%
Maintains: Hold
Price Target: $332$360
Current: $311.20
Upside: +15.68%
Maintains: Buy
Price Target: $163$151
Current: $114.42
Upside: +31.97%
Maintains: Buy
Price Target: $11$10
Current: $3.45
Upside: +189.86%
Maintains: Buy
Price Target: $165$207
Current: $114.06
Upside: +81.48%
Maintains: Buy
Price Target: $9$5
Current: $2.52
Upside: +98.41%
Maintains: Hold
Price Target: $28$10
Current: $3.97
Upside: +151.89%